Health · Public Health & Disease · 1 hr ago
COPD affects more than 14 million people in Brazil, survey finds
More than 14 million people in Brazil have COPD, a progressive lung disease that makes it harder to breathe.
It can cause breathlessness, coughing and tiredness, and may make everyday activities such as walking or climbing stairs difficult.
A survey of 255 people with COPD, relatives and caregivers found that only 16% considered the disease well controlled; the survey was not designed to represent all people with COPD.
Nearly all respondents reported persistent symptoms, and 62% said they had at least two serious flare-ups in the previous year.
The findings also point to pressure on health services: 53% had needed emergency care or hospital admission because of COPD.
Brazil updated its national treatment protocol in November 2025 to include new combinations of three medicines, but patients still face access delays; in Minas Gerais, document reviews can take about three months.
COPD affects more than 14 million people in Brazil and is described as the country’s fifth-leading cause of death.
A survey of 255 people with COPD, family members and caregivers found that only 16% considered the disease well controlled.
Nearly all respondents, 98%, reported at least one persistent symptom, such as fatigue or shortness of breath.
The survey also found that 62% had two or more major flare-ups in the previous 12 months, and 53% had needed emergency care or hospitalisation.
Despite a national treatment protocol update in November 2025, some patients face delays accessing medicines.
- Who
- More than 14 million people in Brazil are affected by COPD. The survey was conducted by the Brazilian Association of Asthmatics, with technical support from Colabore com o Futuro.
- What
- A survey reported on the effects of COPD and patients’ experiences with symptoms, flare-ups and access to treatment.
- When
- The article was published on November 19, 2026. The treatment protocol was updated in November 2025.
- Where
- Brazil. The article gives Minas Gerais as an example of delays in reviewing documents for treatment.
- Why
- The survey examined how COPD affects patients and their access to treatment. The sources do not state why the survey was conducted.
This story does not have two clearly opposing sides.
Brazil updated its clinical protocol and treatment guidelines for COPD, including new options for fixed triple therapies.
62% of respondents reported two or more major COPD flare-ups or worsening episodes during this period.
CNN Brasil published its report on COPD in Brazil and the survey findings.
- People affected
- More than 14 million in Brazil
- Leading cause of death
- Fifth
- Survey participants
- 255 people with COPD, family members and caregivers
- Disease well controlled
- 16% of respondents
- Persistent symptoms
- 98% of respondents
- Emergency care or hospitalisation
- 53% of respondents
What people are saying
For people with a severe condition, going without treatment does not mean merely waiting for an administrative process.
It means living with worsening symptoms such as shortness of breath and loss of autonomy to carry out simple daily activities, as well as living with a greater risk of flare-ups and hospitalisations.